ADT vs SBT for prostate cancer

ADT vs SBT for Prostate Cancer

TL;DR: ADT (hormone therapy that stops testosterone) and SBT (starting treatment only when PSA rises) are two different approaches—ADT is continuous treatment, while SBT means watching and waiting. Your doctor will recommend based on your cancer stage, risk level, and overall health.

KEY POINTS:

• ADT = continuous hormone therapy that blocks testosterone to slow cancer growth; SBT = "surveillance-based therapy" or monitoring first, then treating only if PSA rises
• Early-stage, low-risk cancer often uses active surveillance or SBT approaches; advanced cancer typically uses continuous ADT
• ADT has significant side effects (bone loss, weight gain, heart/diabetes risk) that increase the longer you take it
• Your risk group matters most — NCCN Guidelines recommend different approaches based on whether your cancer is low, intermediate, high, or very-high risk
• Life expectancy and symptoms also guide the choice — doctors weigh treatment benefits against quality-of-life impact

NEXT STEP:

Ask your oncologist: "Based on my risk group and stage, do you recommend continuous ADT or a watch-and-wait approach, and why?"

---

[[FULL_ANSWER]]

Understanding ADT vs. SBT: Two Different Treatment Philosophies

ADT (Androgen Deprivation Therapy) and SBT (Surveillance-Based Therapy) represent fundamentally different approaches to managing prostate cancer. Let me explain how doctors think about each one.

---

What Is ADT?

According to the NCCN Guidelines for Patients: Early-Stage Prostate Cancer, androgen deprivation therapy (ADT) is "hormone therapy that stops the body from making testosterone or blocks cancer cells from using testosterone."

How it works:

• Testosterone fuels prostate cancer growth
• ADT either stops your body from making testosterone (through injections like LHRH agonists) or blocks cancer cells from using it (through pills called anti-androgens)
• This can shrink tumors or slow their growth

When ADT is typically used:

• Advanced-stage (metastatic) prostate cancer — almost always gets ADT as the main treatment
• High-risk or very-high-risk early-stage cancer — often combined with radiation therapy
• After surgery — if cancer cells are found in lymph nodes or if PSA rises after treatment

---

What Is SBT (Surveillance-Based Therapy)?

SBT is a watch-and-wait approach where doctors monitor your cancer closely without starting treatment immediately. This includes:

1. Active Surveillance — for low-risk early-stage cancer

   • Regular PSA blood tests (every 3-6 months)
   • Periodic digital rectal exams
   • Sometimes repeat biopsies
   • Treatment only starts if PSA rises or cancer shows signs of progression

2. Observation — for patients with limited life expectancy

   • Less frequent monitoring
   • Focus on symptom management rather than aggressive treatment

According to NCCN Guidelines, "NCCN experts are concerned about overtreatment of early-stage prostate cancer. For many patients with lower risk prostate cancer, observation or active surveillance can be better options than direct treatment."

---

How Doctors Decide: The Risk Group Framework

Your risk group is the most important factor. According to NCCN Guidelines for Patients: Early-Stage Prostate Cancer, risk groups are determined by:

1. PSA level (prostate-specific antigen in your blood)
2. Grade Group (how abnormal cancer cells look under a microscope)
3. Tumor stage (size and spread using the TNM system)
4. Biopsy results (how much cancer is in your prostate)

For LOW-RISK cancer:

• SBT (active surveillance) is often preferred
• ADT is NOT typically recommended
• Reason: Low-risk cancers grow slowly; treatment side effects may outweigh benefits

For INTERMEDIATE-RISK cancer:

• Options include active surveillance, surgery, radiation, or radiation + ADT
• ADT decision depends on other factors (age, life expectancy, patient preference)

For HIGH-RISK or VERY-HIGH-RISK cancer:

• ADT is usually recommended
• Often combined with radiation therapy
• According to NCCN: "Treatment is more aggressive for high-risk and very-high-risk cancer"

For ADVANCED/METASTATIC cancer:

• ADT is the main treatment
• Usually started immediately
• Often combined with other drugs (chemotherapy, newer hormone therapies)

---

The Trade-Off: Benefits vs. Side Effects

Benefits of ADT:

• Can shrink tumors and slow cancer growth
• Improves outcomes when combined with radiation for high-risk cancer
• Extends survival in advanced cancer

Significant Side Effects of ADT (according to NCCN Guidelines):

The longer you take ADT, the greater your risk of:

• Bone loss and fractures (osteoporosis)
• Weight gain and muscle loss
• Fatigue
• Mood changes and depression
• Increased risk of diabetes
• Increased risk of heart disease (particularly concerning in Black patients)
• Breast tenderness and growth

This is why doctors carefully weigh whether the cancer risk justifies continuous hormone therapy.

---

Clinical Reasoning: How Your Doctor Thinks About This Decision

For early-stage, low-risk cancer:

• Doctors ask: "Will this patient benefit more from treatment or from avoiding side effects?"
• Answer: Usually SBT, because low-risk cancers often never become life-threatening
• PSA monitoring catches any change early

For advanced cancer:

• Doctors ask: "Does this patient need immediate treatment to control cancer spread?"
• Answer: Usually yes—ADT is started right away
• The cancer threat outweighs treatment side effects

For intermediate or high-risk cancer:

• Doctors consider: age, life expectancy, overall health, patient preferences
• Some patients get ADT; others get surgery/radiation without ADT
• This is where shared decision-making with your doctor matters most

---

Questions to Ask Your Oncologist

1. What is my risk group, and why? (This determines everything)
2. Based on my risk group, do you recommend ADT, surveillance, or another approach?
3. If you recommend ADT, how long would I take it? (3 months? 6 months? Longer?)
4. What are the specific side effects I should watch for?
5. If I choose surveillance, how often will I have PSA tests and exams?
6. What signs would mean we need to start treatment?
7. Are there clinical trials I should consider? (See NCI's Cancer Information Service at clinicaltrials.gov)

---

Key Takeaway

ADT and SBT are not competing treatments—they're for different situations. Low-risk cancer often benefits from watching and waiting. Advanced cancer almost always needs ADT. Your risk group, stage, age, and overall health determine which approach makes sense for YOU.

Your oncologist will explain your specific situation and recommend the best path forward.

---

This information is for educational purposes only. Always consult your healthcare team for personalized medical advice and decisions.